Cited by 100Gut microbiota and healthAlcohol Consumption and Health EffectsProbiotics and Fermented Foods

Microbiota, a key player in alcoholic liver disease

Open access
Cassard, Anne-Marie, Ciocan, Dragos·2018·Clinical and Molecular Hepatology

Abstract

Alcoholic liver disease (ALD) is a major cause of morbidity and mortality worldwide. Only 20% of heavy alcohol consumers develop alcoholic liver cirrhosis. The intestinal microbiota (IM) has been recently identified as a key player in the severity of liver injury in ALD. Common features of ALD include a decrease of gut epithelial tight junction protein expression, mucin production, and antimicrobial peptide levels. This disruption of the gut barrier, which is a prerequisite for ALD, leads to the passage of bacterial products into the blood stream (endotoxemia). Moreover, metabolites produced by bacteria, such as short chain fatty acids, volatile organic compounds (VOS), and bile acids (BA), are involved in ALD pathology. Probiotic treatment, IM transplantation, or the consumption of dietary fiber, such as pectin, which all alter the ratio of bacterial species, have been shown to improve liver injury in animal models of ALD and to be associated with an improvement in gut barrier function. Although the connections between the microbiota and the host in ALD are well established, the underlying mechanisms are still an active area of research. Targeting the microbiome through the use of prebiotic, probiotic, and postbiotic modalities could be an attractive new approach to manage ALD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3350/cmh.2017.0067

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cassard, A.-M., & Ciocan, D.
Affiliations
Inserm (FR)
Corresponding author
Cassard, Anne-Marie
Venue
Clinical and Molecular Hepatology
Published
2018-06-25
Volume
24
Issue
2
Pages
100-107
ISSN
  • 2287-2728 (ISSN-L)
  • 2287-285X
OpenAlex
W2780202366
Cited by
100
References
64
Citations by year
2026: 7 · 2025: 8 · 2024: 14 · 2023: 9 · 2022: 10 · 2021: 20 · 2020: 10 · 2019: 14 · 2018: 8
FWCI
0.82
Type
journal article
Language
en
Open access
Locations
  • Clinical and Molecular Hepatology (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Agence Nationale de la Recherche (ANR-10-LABX-0033)
  • Institut National de la Santé et de la Recherche Médicale
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Keywords
alcoholic liver disease, gut microbiota, intestinal barrier dysfunction, tight junction proteins, mucin, antimicrobial peptides, endotoxemia, short-chain fatty acids, volatile organic compounds, bile acids, probiotics, prebiotics, postbiotics, microbiota transplantation, pectin, dietary fiber, alcoholic cirrhosis
MeSH terms
Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Animals, Bacteria, Dietary Fiber, Fungi, Humans, Liver Diseases, Alcoholic, Severity of Illness Index, Probiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review